Trial Profile
Compassionate Use of Defibrotide for Patients With Veno-Occlusive Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Apr 2017
Price :
$35
*
At a glance
- Drugs Defibrotide (Primary)
- Indications Embolism and thrombosis; Veno-occlusive disorders
- Focus Expanded access; Therapeutic Use
- Acronyms DETIDE
- 08 Dec 2015 Results of sub group analysis presented at the 57th Annual Meeting and Exposition of the American Society of Hematology
- 23 Jun 2009 Lead trial investigator changed from Hale GA to Leung D as reported by ClinicalTrials.gov.
- 27 Nov 2005 New trial record.